Reversible Ca2+-dependent Translocation of Protein Kinase C and Glucose-induced Insulin Release*

  1. Jude T. Deeney§,
  2. Barbara A. Cunningham,
  3. Shefali Chheda,
  4. Krister Bokvist,
  5. Lisa Juntti-Berggren§,
  6. Kenny Lam,
  7. Helen M. Korchak,
  8. Barbara E. Corkey and
  9. Per-Olof Berggren§
  1. From the Boston University Medical Center, Diabetes and Metabolism Unit, Boston, Massachusetts 02118,
  2. § The Rolf Luft Center for Diabetes Research, Department of Molecular Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden, and the
  3. University of Pennsylvania, Immunology Division, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104
  1. ” To whom correspondence should be addressed:
    The Rolf Luft Center for Diabetes Research, Dept. of Molecular Medicine, Karolinska Institute, Karolinska Hospital, S-171 76 Stockholm, Sweden.
    Tel.: 46-8-729-5731; Fax: 46-8-729-5731.
  • Permanent address: Dept. of Physiology and Pharmacology, Division of Biophysics, University of Göteborg, Medicinaregatan 11, S-413 90 Göteborg, Sweden.

Abstract

It has been reported that protein kinase C (PKC) interacts at multiple sites in β-cell stimulus-secretion coupling. Nevertheless, there is still controversy concerning the importance of this enzyme in glucose-induced insulin release. The present study was undertaken to clarify whether glucose, directly, or through changes in cytoplasmic free Ca2+ concentration, [Ca2+]i, could promote translocation of PKC from the soluble to the membrane compartment. Whereas glucose, which increases [Ca2+]i, did not affect long-term distribution of PKC activity between soluble and membrane fractions, this distribution was reversibly affected acutely by the Ca2+ concentration in the extraction media. Translocation of PKC to the membrane by incubation of HIT cells for 10 min in the presence of 20 nM phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) resulted in a 5-fold increase in glucose-induced insulin release. This was prevented by 50 nM concentration of the PKC inhibitor staurosporine, provided that the cells were exposed to the inhibitor before the phorbol ester. Cells pretreated with TPA demonstrated increased insulin secretion in response to glucose for several hours. This time course extended beyond the disappearance of [3H]TPA from the cells, which was complete after 1 h. Activation of PKC increased both average insulin release and the amplitude of oscillations 2-fold, but did not affect oscillation frequency. The stimulatory effect of increased PKC activity on insulin release was not matched by changes in [Ca2+]i. We suggest that stimulation of the pancreatic β-cell with glucose promotes transient translocation of certain PKC isoforms from the cytoplasm to the plasma membrane as a direct consequence of the increase in [Ca2+]i. Such a translocation may promote phosphorylation of one or several proteins involved in the regulation of the β-cell stimulus-secretion coupling. This results in potentiation of glucose-induced activation of insulin exocytosis, an effect then not mediated by an increase in [Ca2+]i per se. Hence, pulsatile insulin release can be obtained under conditions where overall [Ca2+]i does not change, challenging the view that oscillations in [Ca2+]i are indeed driving the oscillations in hormone release.

Footnotes

  • * This study was supported by United States Public Health Service Grants DK-35914 and DK-46200, the Juvenile Diabetes Foundation International, by Grants 03X-09890 and 19X-00034 from the Swedish Medical Research Council, the Swedish Diabetes Association, Funds of the Karolinska Institute, the Swedish Society for Medicine, the Nordic Insulin Foundation, the Clas Groschinsky Memorial Foundation, and the Magnus Bergvalls Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    [Ca2+]i

    cytoplasmic free Ca2+ concentration

    TPA

    12-O-tetradecanoylphorbol-13-acetate

    DiC8

    1,2-dioctanoyl-sn-glycerol

    PLC

    phospholipase C system

    DAG

    diacylglycerol

    PKC

    protein kinase C.

    • Received January 18, 1996.
    • Revision received April 17, 1996.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement